Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying Hong

Showing results (1161-1170 of 1,220) with videos related to

Pageof 122
Sort By:
Frontiers in Immunology|September 25, 2023
Neuroinflammation, autoinflammation, splenomegaly and anemia caused by bi-allelic mutations in <i>IRAK4</i>Samantha Cooray, Fiona Price-Kuehne, Ying Hong, et al.
International Journal of Cancer|April 18, 2014
Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trialFeng-Cai Zhu, Wen Chen, Yue-Mei Hu, et al.
Cancer Cell International|November 16, 2019
CDK5RAP3 inhibits angiogenesis in gastric neuroendocrine carcinoma by modulating AKT/HIF-1α/VEGFA signalingJian-Xian Lin, Xiong-Feng Weng, Xin-Sheng Xie, et al.
Obstetrics and Gynecology|November 7, 2018
Cervical Screening by Pap Test and Visual Inspection Enabling Same-Day Biopsy in Low-Resource, High-Risk CommunitiesLin Tao, A Amanguli, Feng Li, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Brain-wide Genome Editing via STEP-RNPs for Treatment of Angelman SyndromeXiaona Lu, Ying Xie, Youmei Bao, et al.
Plos One|March 4, 2014
Overweight and obesity among low-income Muslim Uyghur women in far western China: correlations of body mass index with blood lipids and implications in preventive public healthLi Cong, Jin Qiong Zhan, Lan Yang, et al.
BJS Open|September 20, 2022
Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world studyWei-Feng Qu, Zhen-Bin Ding, Xu-Dong Qu, et al.
Science Advances|May 2, 2025
Targeting HMGB2 acts as dual immunomodulator by bolstering CD8<sup>+</sup> T cell function and inhibiting tumor growth in hepatocellular carcinomaWei-Feng Qu, Gui-Qi Zhu, Rui Yang, et al.
Theranostics|August 2, 2019
Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk FactorsJia-Cheng Lu, Hai-Ying Zeng, Qi-Man Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2018
Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular CarcinomaWei Guo, Yun-Fan Sun, Min-Na Shen, et al.
Pageof 122

Showing results (1161-1170 of 1,220) with videos related to

Sort By:
Pageof 122
Frontiers in Immunology|September 25, 2023
Neuroinflammation, autoinflammation, splenomegaly and anemia caused by bi-allelic mutations in <i>IRAK4</i>Samantha Cooray, Fiona Price-Kuehne, Ying Hong, et al.
International Journal of Cancer|April 18, 2014
Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trialFeng-Cai Zhu, Wen Chen, Yue-Mei Hu, et al.
Cancer Cell International|November 16, 2019
CDK5RAP3 inhibits angiogenesis in gastric neuroendocrine carcinoma by modulating AKT/HIF-1α/VEGFA signalingJian-Xian Lin, Xiong-Feng Weng, Xin-Sheng Xie, et al.
Obstetrics and Gynecology|November 7, 2018
Cervical Screening by Pap Test and Visual Inspection Enabling Same-Day Biopsy in Low-Resource, High-Risk CommunitiesLin Tao, A Amanguli, Feng Li, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Brain-wide Genome Editing via STEP-RNPs for Treatment of Angelman SyndromeXiaona Lu, Ying Xie, Youmei Bao, et al.
Plos One|March 4, 2014
Overweight and obesity among low-income Muslim Uyghur women in far western China: correlations of body mass index with blood lipids and implications in preventive public healthLi Cong, Jin Qiong Zhan, Lan Yang, et al.
BJS Open|September 20, 2022
Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world studyWei-Feng Qu, Zhen-Bin Ding, Xu-Dong Qu, et al.
Science Advances|May 2, 2025
Targeting HMGB2 acts as dual immunomodulator by bolstering CD8<sup>+</sup> T cell function and inhibiting tumor growth in hepatocellular carcinomaWei-Feng Qu, Gui-Qi Zhu, Rui Yang, et al.
Theranostics|August 2, 2019
Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk FactorsJia-Cheng Lu, Hai-Ying Zeng, Qi-Man Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2018
Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular CarcinomaWei Guo, Yun-Fan Sun, Min-Na Shen, et al.
Pageof 122